The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA)

OBJECTIVES: To elucidate antibody responses after the second and third dose of COVID-19 vaccine in patients with inflammatory rheumatic diseases (IRD) treated with biologic/targeted disease modifying anti-rheumatic drugs (b/ts DMARDs). METHODS: Antibody levels to antigens representing spike full len...

Descripción completa

Detalles Bibliográficos
Autores principales: Frodlund, Martina, Nived, Per, Chatzidionysiou, Aikaterini, Södergren, Anna, Klingberg, Eva, Bengtsson, Anders, Hansson, Monika, Olsson, Sophie, Pin, Elisa, Klareskog, Lars, Kapetanovic, Meliha C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070777/
https://www.ncbi.nlm.nih.gov/pubmed/37076360
http://dx.doi.org/10.1016/j.vaccine.2023.03.065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070777/
https://www.ncbi.nlm.nih.gov/pubmed/37076360
http://dx.doi.org/10.1016/j.vaccine.2023.03.065

Ejemplares similares